Gross Margin - Intercept Pharmaceuticals Inc (F:I4P) - Alpha Spread
I

Intercept Pharmaceuticals Inc
F:I4P

Watchlist Manager
Intercept Pharmaceuticals Inc
F:I4P
Watchlist
Price: 17.52 EUR Market Closed
Market Cap: 732.8m EUR
Have any thoughts about
Intercept Pharmaceuticals Inc?
Write Note

Gross Margin
Intercept Pharmaceuticals Inc

99.8%
Current
99%
Average
63%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
99.8%
=
Gross Profit
317.1m
/
Revenue
317.7m

Gross Margin Across Competitors

Country US
Market Cap 732.5m EUR
Gross Margin
100%
Country US
Market Cap 341.5B USD
Gross Margin
67%
Country US
Market Cap 180.5B USD
Gross Margin
63%
Country US
Market Cap 129B USD
Gross Margin
87%
Country US
Market Cap 123.6B USD
Gross Margin
86%
Country US
Market Cap 105B USD
Gross Margin
77%
Country US
Market Cap 94.1B EUR
Gross Margin
76%
Country AU
Market Cap 142.3B AUD
Gross Margin
52%
Country US
Market Cap 39.3B EUR
Gross Margin
75%
Country US
Market Cap 38.5B USD
Gross Margin
97%
Country US
Market Cap 35.2B USD
Gross Margin
87%

Profitability Report

View the profitability report to see the full profitability analysis for Intercept Pharmaceuticals Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
99.8%
=
Gross Profit
317.1m
/
Revenue
317.7m
What is the Gross Margin of Intercept Pharmaceuticals Inc?

Based on Intercept Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 99.8%.